Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

125.10p
   
  • Change Today:
      0.100p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 21,785
  • Market Cap: £131.07m
  • RiskGrade: 90
  • Beta: 0.00

Cello Health Overview

Cello Health is in the health care sector and is currently trading at 125.10p per share. In the last year Cello Health's share price has ranged from 96.00p to 139.50p and brokers are currently rating this stock as 'strong buy'.

Key Personnel

CEO: Mark Scott
Executive Director: Julia Ralston
Group COO: Stephen Highley
Group Finance Director: Mark Bentley
Independent Non-Executive Director: Jo LeCouilliard
Independent Non-Executive Director: Clifford Tompsett
Non-Executive Chairman: Christopher Jones
Non-Executive Dir: Michele Luzi

Contact Details

Address: Queens House, 8-9 Queen Street, London, United Kingdom, EC4N 1SP
Phone: +44 (0)20 7812 8460
Fax: +44 (0)20 7253 5376

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B0310763

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 125.10p
Change Today 0.100p
% Change 0.08 %
52 Week High 139.50
52 Week Low 96.00
Volume 21,785
Shares Issued 104.77m
Market Cap £131.07m
Beta 0.00
RiskGrade 90

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.47% below the market average54.47% below the market average54.47% below the market average54.47% below the market average54.47% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
37.21% above the market average37.21% above the market average37.21% above the market average37.21% above the market average37.21% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income
22.39% below the market average22.39% below the market average22.39% below the market average22.39% below the market average22.39% below the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average
Growth
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 24-Jun-2019

Time Volume / Share Price
10:06 7,472 @ 125.10p
09:12 9,345 @ 126.50p
08:35 773 @ 125.00p
08:23 2,097 @ 126.00p
08:15 2,098 @ 126.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page